Morgan Stanley’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Sell
17,093
-6,706
-28% -$125K ﹤0.01% 5674
2025
Q4
$375K Buy
23,799
+13,975
+142% +$204K ﹤0.01% 5660
2025
Q3
$131K Buy
9,824
+900
+10% +$7.89K ﹤0.01% 6044
2025
Q2
$76K Buy
8,924
+6,800
+320% +$43.9K ﹤0.01% 6223
2025
Q1
$8.33K Hold
2,124
﹤0.01% 6853
2024
Q4
$12.3K Sell
2,124
-250
-11% -$1.21K ﹤0.01% 6732
2024
Q3
$9.5K Buy
+2,374
New +$12.4K ﹤0.01% 6731

Other funds holding PRE

Morgan Stanley's PRE Position: Q1 2026 in Review

Morgan Stanley reduced its Prenetics Global (PRE) stake by 28% in Q1 2026, selling an estimated $125K and leaving 17,093 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #5674.

Morgan Stanley first reported a position in PRE in Q3 2024 and has held it in 7 quarters since. The position peaked at $375K in Q4 2025. 34 funds tracked by Wall St. Rank hold PRE as of Q1 2026.

  • Morgan Stanley held 17,093 shares of Prenetics Global worth $330K as of Q1 2026.
  • Morgan Stanley sold 6,706 Prenetics Global shares in Q1 2026, an estimated $125K.
  • Prenetics Global made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5674 holding.
  • Morgan Stanley first reported a position in Prenetics Global in Q3 2024 and has held it in 7 quarters since.
  • Morgan Stanley's Prenetics Global position peaked at $375K in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Prenetics Global as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.